GandeviaB. Historical review of the use of parasympatholytic agents in the treatment of respiratory disorders. Postgrad Med J, 1975; 51(7 Suppl):13–20.
2.
RaimondiAC, SchottlenderJ, LombardiD, MolfinoNA. Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. Chest, 1997; 112(1):24–28.
3.
AriA. Aerosol Therapy in Pulmonary Critical Care. Respir Care, 2015; 60(6):858–874; discussion 874-859.
4.
AriA, FinkJB, DhandR. Inhalation therapy in patients receiving mechanical ventilation: an update. J Aerosol Med Pulm Drug Deliv, 2012; 25(6):319–332.
5.
DhandR. Aerosol delivery during mechanical ventilation: from basic techniques to new devices. J Aerosol Med Pulm Drug Deliv, 2008; 21(1):45–60.
6.
DiotP, MorraL, SmaldoneGC. Albuterol delivery in a model of mechanical ventilation: comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med, 1995; 152(4):1391–1394.
7.
BerlinskiA. Assessing new technologies in aerosol medicine: strengths and limitations. Respir Care, 2015; 60(6):833–847; discussion 847-839.
8.
DhandR. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care, 2002; 47(12):1406–1416; discussion 1416-1408.
9.
DhandR, GunturVP. How best to deliver aerosol medications to mechanically ventilated patients. Clin Chest Med, 2008; 29(2):277–296, vi.
10.
SafdarN, CrnichCJ, MakiDG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care, 2005; 50(6):725–739; discussion 739-741.
11.
HamillRJ, HoustonED, GeorghiouPR, WrightCE, KozaMA, CadleRM, et al. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med, 1995; 122(10):762–766.
12.
HessDR, KallstromTJ, MottramCD, MyersTR, SorensonHM, VinesDL. Care of the ventilator circuit and its relation to ventilator-associated pneumonia. Respir Care, 2003; 48(9):869–879.
13.
DuboskyM, ChenY, HenricksenM, VinesD. Vibrating mesh nebulizer compared with metered-dose inhaler in mechanically ventilated patients. Respir Care, 2017; 62(4):391–395.
14.
AriA, AtalayOT, HarwoodR, SheardMM, AljamhanEA, FinkJB. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respiratory care, 2010; 55(7):845–851.
15.
TejerinaE, Frutos-VivarF, RestrepoMI, AnzuetoA, AbrougF, PalizasF, et al. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care, 2006; 21(1):56–65.
16.
MelsenWG, RoversMM, GroenwoldRH, BergmansDC, CamusC, BauerTT, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis, 2013; 13(8):665–671.
17.
CravenDE, LichtenbergDA, GoularteTA, MakeBJ, McCabeWR. Contaminated medication nebulizers in mechanical ventilator circuits: source of bacterial aerosols. Am J Med, 1984; 77(5):834–838.
18.
CravenDE, KunchesLM, KilinskyV, LichtenbergDA, MakeBJ, McCabeWR. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis, 1986; 133(5):792–796.
19.
MagillSS, KlompasM, BalkR, BurnsSM, DeutschmanCS, DiekemaD, et al. Developing a new, national approach to surveillance for ventilator-associated events. Am J Crit Care, 2013; 22(6):469–473.
20.
KlompasM, BerraL. Should ventilator-associated events become a quality indicator for ICUs?. Respir Care, 2016; 61(6):723–736.
21.
GowanM, BushwitzJ, WattsP, SilverPC, JacksonM, HamptonN, KollefMH. Use of a shared canister protocol for the delivery of metered-dose inhalers in mechanically ventilated subjects. Respir Care, 2016; 61(10):1285–1292.
22.
GowdaAA, CucciaAD, SmaldoneGC. Reliability of vibrating mesh technology. Respir Care, 2017; 62(1):65–69.
